Ocugen (OCGN) Short Interest Ratio & Short Volume $0.97 -0.01 (-1.39%) As of 06/30/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Ocugen Short Interest DataOcugen (OCGN) has a short interest of 65.19 million shares, representing 23.36% of the float (the number of shares available for trading by the public). This marks a -4.79% decrease in short interest from the previous month. The short interest ratio (days to cover) is 13.7, indicating that it would take 13.7 days of the average trading volume of 4.62 million shares to cover all short positions.Current Short Interest65,190,000 sharesPrevious Short Interest68,470,000 sharesChange Vs. Previous Month-4.79%Dollar Volume Sold Short$73.66 millionShort Interest Ratio13.7 Days to CoverLast Record DateJune 15, 2025Outstanding Shares292,030,000 sharesShort Percent of Float23.36%Today's Trading Volume10,937,698 sharesAverage Trading Volume4,616,460 sharesToday's Volume Vs. Average237% Short Selling Ocugen? Sign up to receive the latest short interest report for Ocugen and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOCGN Short Interest Over TimeOCGN Days to Cover Over TimeOCGN Percentage of Float Shorted Over Time Ocugen Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/202565,190,000 shares $73.66 million -4.8%23.4%13.7 $1.13 5/31/202568,470,000 shares $57.81 million -1.6%24.6%15.8 $0.84 5/15/202569,600,000 shares $49.37 million +2.0%25.0%17 $0.71 4/30/202568,230,000 shares $50.98 million -0.6%N/A18.1 $0.75 4/15/202568,670,000 shares $47.99 million +4.4%24.6%18.1 $0.70 3/31/202565,790,000 shares $46.71 million -2.6%23.6%16.3 $0.71 3/15/202567,510,000 shares $36.27 million +6.0%24.2%14.7 $0.54 2/28/202563,670,000 shares $41.49 million +5.7%22.8%13.7 $0.65 2/15/202560,260,000 shares $43.26 million +2.3%21.6%13.4 $0.72 1/31/202558,880,000 shares $42.83 million +4.9%N/A12.4 $0.73 Get the Latest News and Ratings for OCGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ocugen and its competitors with MarketBeat's FREE daily newsletter. 1/15/202556,110,000 shares $40.90 million +7.4%N/A11.8 $0.73 12/31/202452,260,000 shares $42.07 million -10.9%N/A11.9 $0.81 12/15/202458,630,000 shares $50.27 million +2.9%N/A14 $0.86 11/30/202457,000,000 shares $55.97 million +4.8%N/A15.5 $0.98 11/15/202454,400,000 shares $51.06 million +7.4%N/A15 $0.94 10/31/202450,650,000 shares $46.14 million -2.5%N/A14.2 $0.91 10/15/202451,920,000 shares $49.17 million +2.6%N/A13.2 $0.95 9/30/202450,620,000 shares $50.23 million -0.6%N/A11.9 $0.99 9/15/202450,900,000 shares $61.59 million -0.6%N/A9.7 $1.21 8/31/202451,230,000 shares $66.60 million -0.1%N/A9.5 $1.30 8/15/202451,270,000 shares $67.16 million -19.9%N/A9.2 $1.31 7/31/202464,030,000 shares $89.96 million +4.1%N/A10.1 $1.41 7/15/202461,520,000 shares $117.50 million +15.8%N/A9.6 $1.91 6/30/202453,120,000 shares $82.34 million +8.3%N/A7.6 $1.55 6/15/202449,060,000 shares $69.67 million +1.6%N/A5.9 $1.42 5/31/202448,310,000 shares $83.58 million -7.2%N/A5.6 $1.73 5/15/202452,080,000 shares $102.08 million +8.8%N/A5.7 $1.96 4/30/202447,890,000 shares $63.21 million +5.9%N/A4.9 $1.32 4/15/202445,230,000 shares $71.92 million +4.0%N/A5 $1.59 3/31/202443,480,000 shares $71.31 million +22.8%N/A5.3 $1.64 3/15/202435,400,000 shares $38.23 million -3.4%N/A4.5 $1.08 2/29/202436,650,000 shares $34.30 million +50.5%N/A6.7 $0.94 2/15/202424,360,000 shares $18.17 million +2.7%N/A5 $0.75 1/31/202423,710,000 shares $12.71 million -8.6%N/A9.3 $0.54 1/15/202425,950,000 shares $15.53 million +10.4%N/A10.2 $0.60 12/31/202323,510,000 shares $13.52 million +5.6%N/A9.6 $0.58 12/15/202322,270,000 shares $8.41 million -6.5%N/A12.3 $0.38 11/30/202323,820,000 shares $9.21 million -5.4%N/A17.3 $0.39 11/15/202325,180,000 shares $9.56 million +2.0%N/A16.6 $0.38 10/31/202324,690,000 shares $9.08 million -2.6%N/A11.7 $0.37A grave, grave error. (Ad)Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the key to unlocking technological breakthroughs we once thought were impossible. And it may just be the only thing capable of bringing America back from the brink of recession – despite Washington’s incompetence and addiction to reckless spending. That’s why Elon Musk, Jeff Bezos, Jensen Huang, and even Bill Gates are pouring billions into the infrastructure behind it.They know what’s coming. 10/15/202325,360,000 shares $10.61 million +0.6%N/A10 $0.42 9/30/202325,220,000 shares $10.09 million +3.7%N/A7.9 $0.40 9/15/202324,330,000 shares $9.96 million -4.7%N/A5.6 $0.41 8/31/202325,520,000 shares $11.00 million +3.4%N/A4.7 $0.43 8/15/202324,680,000 shares $11.76 million -0.6%N/A3.4 $0.48 7/31/202324,830,000 shares $15.27 million -2.3%N/A3.3 $0.62 7/15/202325,410,000 shares $14.83 million -5.7%N/A3.2 $0.58 6/30/202326,940,000 shares $14.63 million -27.7%N/A3.5 $0.54 6/15/202337,250,000 shares $19.99 million -10.9%N/A5 $0.54 5/31/202341,790,000 shares $19.22 million +2.5%N/A5.6 $0.46 5/15/202340,760,000 shares $29.92 million +2.0%N/A6.2 $0.73 4/30/202339,950,000 shares $28.51 million +6.4%N/A6.4 $0.71 4/15/202337,540,000 shares $30.04 million +1.2%N/A6.1 $0.80 3/31/202337,100,000 shares $31.65 million -27.1%N/A5.5 $0.85 3/15/202350,880,000 shares $46.88 million +2.9%N/A7.5 $0.92 2/28/202349,470,000 shares $49.28 million +4.4%N/A8.6 $1.00 2/15/202347,390,000 shares $52.13 million +5.4%N/A9 $1.10 1/31/202344,970,000 shares $57.11 million +0.9%N/A8.6 $1.27 1/15/202344,590,000 shares $57.97 million +9.7%N/A8.8 $1.30 12/30/202240,650,000 shares $52.85 million +0.3%N/A8.3 $1.30 12/15/202240,530,000 shares $58.77 million +0.5%N/A8.8 $1.45 11/30/202240,350,000 shares $62.95 million -2.8%N/A8.6 $1.56 11/15/202241,530,000 shares $71.43 million -4.0%N/A8.6 $1.72 10/31/202243,270,000 shares $74.42 million +0.1%N/A8.6 $1.72 10/15/202243,210,000 shares $67.41 million -1.3%N/A8.6 $1.56 9/30/202243,790,000 shares $77.95 million +6.6%N/A8.5 $1.78 9/15/202241,080,000 shares $96.95 million -9.4%N/A7.8 $2.36 8/31/202245,340,000 shares $116.98 million -7.6%N/A8.1 $2.58 8/15/202249,070,000 shares $141.32 million -11.9%N/A8.2 $2.88 7/31/202255,700,000 shares $143.71 million +3.3%N/A8.7 $2.58 7/15/202253,940,000 shares $139.17 million -1.1%N/A8.1 $2.58 6/30/202254,540,000 shares $123.81 million -0.3%N/A7.8 $2.27 6/15/202254,690,000 shares $113.76 million -8.4%N/A7.6 $2.08 5/31/202259,720,000 shares $141.54 million +3.2%N/A7.2 $2.37 5/15/202257,850,000 shares $121.49 million -1.3%N/A5.3 $2.10 4/30/202258,600,000 shares $128.33 million +8.7%N/A5.5 $2.19 4/15/202253,910,000 shares $148.79 million -2.4%N/A4.7 $2.76 3/31/202255,230,000 shares $182.26 million +14.7%N/A4.5 $3.30 3/15/202248,140,000 shares $130.46 million -6.1%N/A3.6 $2.71 2/28/202251,290,000 shares $180.54 million -5.9%N/A3.7 $3.52 2/15/202254,510,000 shares $212.59 million -0.8%N/A3.9 $3.90 1/31/202254,940,000 shares $195.04 million +1.2%30.2%3.8 $3.55 1/15/202254,310,000 shares $230.82 million -1.7%27.9%1.9 $4.25 12/31/202155,220,000 shares $251.25 million +1.7%28.4%1.7 $4.55 12/15/202154,300,000 shares $294.31 million +9.8%27.8%1.6 $5.42 11/30/202149,470,000 shares $313.64 million +5.4%25.3%1.5 $6.34 11/15/202146,930,000 shares $389.52 million -14.3%24.1%1.5 $8.30 10/29/202154,770,000 shares $648.48 million -3.9%28.2%1.8 $11.84 10/15/202156,980,000 shares $493.45 million +7.4%29.4%2.9 $8.66 9/30/202153,080,000 shares $381.11 million +0.6%27.4%4 $7.18A grave, grave error. (Ad)Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the key to unlocking technological breakthroughs we once thought were impossible. And it may just be the only thing capable of bringing America back from the brink of recession – despite Washington’s incompetence and addiction to reckless spending. That’s why Elon Musk, Jeff Bezos, Jensen Huang, and even Bill Gates are pouring billions into the infrastructure behind it.They know what’s coming. 9/15/202152,750,000 shares $397.21 million +3.3%27.2%3.3 $7.53 8/31/202151,080,000 shares $387.70 million -5.7%26.3%2.4 $7.59 8/13/202154,180,000 shares $402.02 million +1.5%27.9%2 $7.42 7/30/202153,390,000 shares $358.25 million +2.2%27.5%1.6 $6.71 7/15/202152,250,000 shares $332.31 million +3.3%27.0%0.8 $6.36 6/30/202150,590,000 shares $406.24 million +2.6%26.2%0.8 $8.03 6/15/202149,310,000 shares $308.68 million +14.7%25.5%0.7 $6.26 5/28/202142,980,000 shares $375.22 million +12.9%22.2%0.7 $8.73 5/14/202138,080,000 shares $313.40 million +2.8%19.7%0.6 $8.23 4/30/202137,030,000 shares $442.88 million +6.5%19.2%0.5 $11.96 4/15/202134,770,000 shares $239.91 million +28.2%19.0%0.5 $6.90 3/31/202127,130,000 shares $183.13 million +108.4%14.9%0.5 $6.75 3/15/202113,020,000 shares $130.20 million +4.8%7.1%0.1 $10.00 2/26/202112,430,000 shares $99.44 million +52.3%6.8%0.1 $8.00 2/12/20218,160,000 shares $89.68 million -28.0%4.5%0.1 $10.99 1/29/202111,340,000 shares $20.64 million -23.4%7.2%0.1 $1.82 1/15/202114,800,000 shares $32.26 million -16.2%9.5%0.3 $2.18 12/31/202017,660,000 shares $34.79 million +254.6%11.3%0.4 $1.97 12/15/20204,980,000 shares $1.47 million +19.7%3.2%0.1 $0.30 11/30/20204,160,000 shares $1.24 million -19.1%2.7%0.5 $0.30 11/15/20205,140,000 shares $1.48 million -5.7%3.3%0.6 $0.29 10/30/20205,450,000 shares $1.59 million -11.5%3.5%0.7 $0.29 10/15/20206,160,000 shares $2.06 million +0.8%4.0%0.2 $0.33 9/30/20206,110,000 shares $1.89 million +35.8%4.7%0.2 $0.31 9/15/20204,500,000 shares $1.48 million -9.1%3.5%0.1 $0.33 8/31/20204,950,000 shares $1.72 million -18.2%3.8%0.1 $0.35 8/14/20206,050,000 shares $3.42 million -8.3%4.7%0.2 $0.56 7/31/20206,600,000 shares $3.40 million +6,022.5%5.1%0.2 $0.52 7/15/2020107,800 shares $23.09 thousand -66.8%0.1%0 $0.21 OCGN Short Interest - Frequently Asked Questions What is Ocugen's current short interest? Short interest is the volume of Ocugen shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 65,190,000 shares of OCGN short. 23.36% of Ocugen's shares are currently sold short. Learn More on Ocugen's current short interest. What is a good short interest ratio for Ocugen? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OCGN shares currently have a short interest ratio of 14.0. Learn More on Ocugen's short interest ratio. Which institutional investors are shorting Ocugen? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Ocugen: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Ocugen? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 23.36% of Ocugen's floating shares are currently sold short. Is Ocugen's short interest increasing or decreasing? Ocugen saw a decline in short interest in June. As of June 15th, there was short interest totaling 65,190,000 shares, a decline of 4.8% from the previous total of 68,470,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Ocugen's short interest compare to its competitors? 23.36% of Ocugen's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Ocugen: CorMedix Inc (13.37%), WAVE Life Sciences Ltd. (13.49%), Aurinia Pharmaceuticals Inc (8.82%), Enliven Therapeutics, Inc. (17.08%), AbCellera Biologics Inc. (11.84%), Phibro Animal Health Corporation (4.91%), Verve Therapeutics, Inc. (27.37%), Collegium Pharmaceutical, Inc. (15.65%), Akebia Therapeutics, Inc. (7.26%), Intellia Therapeutics, Inc. (29.58%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Ocugen stock? Short selling OCGN is an investing strategy that aims to generate trading profit from Ocugen as its price is falling. OCGN shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ocugen? A short squeeze for Ocugen occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OCGN, which in turn drives the price of the stock up even further. How often is Ocugen's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OCGN, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies CRMD Short Interest Data WVE Short Interest Data AUPH Short Interest Data ELVN Short Interest Data ABCL Short Interest Data PAHC Short Interest Data VERV Short Interest Data COLL Short Interest Data AKBA Short Interest Data NTLA Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OCGN) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredNvidia’s Huang: AI is going to need 100x more power12Nvidia CEO Jensen Huang didn't mince words. After Nvidia's latest earnings call, Huang said AI now requires...Weiss Ratings | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocugen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ocugen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
